Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis
NCT ID: NCT03967210
Last Updated: 2021-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
132 participants
OBSERVATIONAL
2019-07-05
2020-01-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC
NCT05492539
Epidemiology of Klebsiella Pneumoniae in China
NCT03598543
Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
NCT00518661
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025
PREdiction of CEphalosporinase Producing Enterobacteria During Ventilator-associated Pneumonia for Therapeutic Stewardship
NCT05486130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with meningitis Klebsiella sp., hospitalized in one of the hospitals of the Clinical Microbiology Group
* Francophone patient
Exclusion Criteria
* Patient deprived of liberty
* Patient under safeguard of justice
* Patient opposing his participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Hôpital Saint-Joseph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoit PILMIS, MD
Role: STUDY_DIRECTOR
Fondation Hôpital Saint-Joseph
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Brest
Brest, , France
CHU Caen
Caen, , France
Hôpital henri Mondor
Créteil, , France
CHU Lyon
Lyon, , France
CHU Nantes
Nantes, , France
CHU Nice
Nice, , France
Hôpital Lariboisière
Paris, , France
Groupe Hospitalier Paris Saint-Joseph
Paris, , France
Hôpital Cochin
Paris, , France
CHU Kremlin Bicetre
Paris, , France
Hôpital Foch
Paris, , France
Hôpital Necker Enfants Malades
Paris, , France
Hôpital Sainte Anne
Paris, , France
CHU Poitiers
Poitiers, , France
CHU Reims
Reims, , France
CHU Rennes
Rennes, , France
CHU Strasbourg
Strasbourg, , France
CHU Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KlebsieLCR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.